Biocon Limited Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹440.7Market Cap
₹ 71,250 Cr.Stock P/E
183ROE
1.40 %RSI
61.52Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)
Biocon Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Biocon Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Biocon Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 440.7 |
| RSI (14) | 61.52 |
| 50 DMA | 418.96 |
| 200 DMA | 386.64 |
| Trend | Bullish |
| A/D Rating | B |
| RS Rating | 79 |
| EPS Rating | 5 |
| TI65 | 1.04 |
| TI65 Trend | Neutral |
Pivot Points Analysis
Daily pivot points for Biocon Limited calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹450.35 |
| R2 | ₹445.8 |
| R1 | ₹440.2 |
| PP | ₹435.65 |
| S1 | ₹430.05 |
| S2 | ₹425.5 |
| S3 | ₹419.9 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 71,250 Cr. |
| Current Price | ₹ 437 |
| High / Low | ₹ 447 / 331 |
| Stock P/E | 183 |
| Book Value | ₹ 210 |
| Dividend Yield | 0.11 % |
| ROCE | 3.61 % |
| ROE | 1.40 % |
| Face Value | ₹ 5.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Mar 2023 | 3,774 | 414 | 25% |
| Jun 2023 | 3,423 | 149 | 20% |
| Sep 2023 | 3,462 | 173 | 21% |
| Dec 2023 | 3,954 | 753 | 23% |
| Mar 2024 | 3,917 | 223 | 23% |
| Jun 2024 | 3,433 | 862 | 18% |
| Sep 2024 | 3,590 | 27 | 19% |
| Dec 2024 | 3,821 | 81 | 20% |
| Mar 2025 | 4,417 | 459 | 24% |
| Jun 2025 | 3,942 | 89 | 19% |
| Sep 2025 | 4,296 | 133 | 19% |
| Dec 2025 | 4,173 | -52 | 20% |
| Mar 2026 | 4,517 | 199 | 23% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 60.68% |
| FIIs | 17.71% |
| DIIs | 3.72% |
| Government | 0.00% |
| Public | 16.12% |
| Others | 1.76% |
| No. of Shareholders | 1,00,761 |
Pros and Cons
Pros
- Strong technical momentum with price holding comfortably above the 50 DMA (418.96).
- Outperforming over 70% of the entire market universe over the past 12 months.
Cons
- Valuation metrics appear elevated with a trailing P/E of 183, demanding high performance requirements.
Related NSE Stocks
UltraTech Cement Limited
View Share Price Analysis →MphasiS Limited
View Share Price Analysis →C.E. Info Systems Limited
View Share Price Analysis →Fortis Healthcare Limited
View Share Price Analysis →Varun Beverages Limited
View Share Price Analysis →Vijaya Diagnostic Centre Limited
View Share Price Analysis →Tata Capital Limited
View Share Price Analysis →Tata Power Company Limited
View Share Price Analysis →JSW Infrastructure Limited
View Share Price Analysis →Acutaas Chemicals Limited
View Share Price Analysis →MMTC Limited
View Share Price Analysis →Acme Solar Holdings Limited
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Biocon Ltd share?
Based on the latest closing data, the technical momentum for Biocon Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 61.52, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (418.96) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Biocon Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Biocon Ltd today centers at a Pivot Point (PP) of ₹435.65. Upside resistance challenges are calculated at R1: ₹440.2, R2: ₹445.8, and R3: ₹450.35. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹430.05, S2: ₹425.5, and S3: ₹419.9.
How does the fundamental ROE and P/E ratio look for Biocon Ltd?
Biocon Ltd is currently trading with a valuation metrics context of a Stock P/E of 183, against a core structural efficiency Return on Equity (ROE) standing at 1.40 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 5, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Biocon Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Speculative Momentum Phase (Neutral / Hold). Biocon Ltd is trading above its 50 ... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of B, a Relative Strength (RS) ranking of 79, and long-term trend backing from the TI65 indicator (Neutral pattern).